title: Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
abstract: OBJECTIVE
  The aims of this study were to generate normal values of aminoterminal pro-brain natriuretic peptide in children with a bidirectional Glenn anastomosis without congestive heart failure and to test the hypothesis that plasma levels of aminoterminal pro-brain natriuretic peptide correlate with the clinical severity of congestive heart failure and morbidity after the Fontan operation.
  
  
  METHODS
  Aminoterminal pro-brain natriuretic peptide plasma levels of 78 patients after the bidirectional Glenn operation with a median age of 3.2 years and a median follow-up time of 3 years were measured by using an automated enzyme immunoassay. The severity of heart failure was quantified by using the New York University Pediatric Heart Failure Index.
  
  
  RESULTS
  The 97.5th percentile of aminoterminal pro-brain natriuretic peptide level in patients without congestive heart failure was 339 pg/mL. Aminoterminal pro-brain natriuretic peptide levels strongly correlated with the New York University Pediatric Heart Failure Index score (P < .001). In patients with congestive heart failure (31/78), the aminoterminal pro-brain natriuretic peptide levels were significantly higher (median, 670 pg/mL) than in patients without congestive heart failure (median, 171 pg/mL). In 41 patients who underwent the Fontan operation, the time to removal of chest tubes and the length of hospital stay positively correlated with the preoperative value of aminoterminal pro-brain natriuretic peptide.
  
  
  CONCLUSIONS
  In children with a bidirectional Glenn anastomosis without signs of heart failure, aminoterminal pro-brain natriuretic peptide levels were within the normal range and correlated with the severity of congestive heart failure. Further studies are needed to determine whether aminoterminal pro-brain natriuretic peptide levels can aide clinicians in the early detection of congestive heart failure in this patient group.
authors.affiliation: Pediatric Cardiology, Children's and Maternity Hospital Linz, Linz, Austria. elechner@aon.at
authors.forename: Evelyn
authors.initials: E
authors.lastname: Lechner
authors.forename: Elisabeth M
authors.initials: EM
authors.lastname: Schreier-Lechner
authors.forename: Anna
authors.initials: A
authors.lastname: Hofer
authors.forename: Roland
authors.initials: R
authors.lastname: Gitter
authors.forename: Rudolf
authors.initials: R
authors.lastname: Mair
authors.forename: Ariane
authors.initials: A
authors.lastname: Biebl
authors.forename: Gerald
authors.initials: G
authors.lastname: Tulzer
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D018729:Fontan Procedure / Q000009:adverse effects*; D018610:Heart Bypass, Right / Q000009:adverse effects; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*; D006439:Hemodynamics; D006801:Humans; D018636:Hypoplastic Left Heart Syndrome / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D007902:Length of Stay; D008297:Male; D032342:Muscle Cells / Q000378:metabolism*; D020097:Natriuretic Peptide, Brain / Q000378:metabolism*; D011446:Prospective Studies
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain